Drugs / Magnesium Threonate
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT06902285 | Apr 2025 → Jul 2027 expected | osteoarthritis, knee | University of Miami | Recruiting | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT06889584 | Feb → Dec 2025 | — | University of South Carolina | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | magnesium threonate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06889584 ↗ |
| Route | Oral | “Participants will receive a daily 145 mg pill by mouth 30 minutes before going to sleep” NCT06902285 ↗ |